During the past decade, SC Clubul Sanatatii SRL conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "SC Clubul Sanatatii SRL" #1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "SC Clubul Sanatatii SRL" are "Multiple Sclerosis, Primary Progressive" (3 trials), "Relapsing Multiple Sclerosis" (2 trials), "Multiple Sclerosis" (1 trials), "Multiple Sclerosis (MS)" (1 trials) and "Multiple Sclerosis, Relapse Free" (1 trials). Many other conditions were trialed in "SC Clubul Sanatatii SRL" in a lesser frequency.

Most popular intervention types in "SC Clubul Sanatatii SRL" are "Drug" (9 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Ocrelizumab" (2 trials), "Ozanimod" (2 trials), "Interferon beta-1a" (1 trials) and "Interferon beta-1a placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "SC Clubul Sanatatii SRL" are 9 trials for "All" genders.

Currently, there are NaN active trials in "SC Clubul Sanatatii SRL". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in SC Clubul Sanatatii SRL, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in SC Clubul Sanatatii SRL, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".